Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluorescein for urine sample authenticity in SUD
NCT07356349Phase 3Not yet recruiting
- Sponsor
- UPTru
- Start
- Jan 2026
- Primary completion
- Sep 2026
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of fluorescein disodium in substance use disorder (SUD), sponsored by UPTru. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
fluorescein disodium
03
Conditions
substance use disorder (SUD)
Beyond the preview
Go deeper on NCT07356349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07356349.